Gao et al. evaluated the degree of BRD4 expression levels in thyroid cancers and the possibility of BRD4 inhibition for cell viability, NIS expression, and RAI uptake (Figure 3A) 186. The gene discussed is SLC5A5; the disease is thyroid gland carcinoma.